Patricia Pautier

16.3k total citations · 2 hit papers
200 papers, 4.8k citations indexed

About

Patricia Pautier is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Patricia Pautier has authored 200 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Reproductive Medicine, 83 papers in Oncology and 74 papers in Obstetrics and Gynecology. Recurrent topics in Patricia Pautier's work include Ovarian cancer diagnosis and treatment (92 papers), Endometrial and Cervical Cancer Treatments (69 papers) and Sarcoma Diagnosis and Treatment (35 papers). Patricia Pautier is often cited by papers focused on Ovarian cancer diagnosis and treatment (92 papers), Endometrial and Cervical Cancer Treatments (69 papers) and Sarcoma Diagnosis and Treatment (35 papers). Patricia Pautier collaborates with scholars based in France, Italy and Spain. Patricia Pautier's co-authors include Philippe Morice, Catherine Lhommé, Pierre Duvillard, Thierry Le Chevalier, Bernard Escudier, Christine Haie-Méder, Laurence Zitvogel, Caroline Flament, Annie Rey and Christophe Pomel and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Patricia Pautier

187 papers receiving 4.7k citations

Hit Papers

Malignant effusions and i... 2002 2026 2010 2018 2002 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Malignant effusions and immunogenic tumour-derived exosomes
    2002 793 citations Caroline Flament, Patricia Pautier et al. profile →
  2. Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
    2021 186 citations Amit M. Oza, Nicoletta Colombo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia Pautier France 33 1.8k 1.6k 1.5k 1.1k 902 200 4.8k
Rochelle L. Garcia United States 34 2.0k 1.1× 1.9k 1.2× 2.1k 1.5× 849 0.8× 528 0.6× 83 5.5k
Oluwole Fadare United States 36 953 0.5× 1.3k 0.8× 1.4k 1.0× 1.5k 1.4× 1.0k 1.1× 255 4.7k
Toru Sugiyama Japan 34 1.3k 0.7× 1.3k 0.8× 3.0k 2.1× 1.8k 1.6× 661 0.7× 234 5.1k
Brooke E. Howitt United States 45 2.1k 1.2× 1.6k 1.0× 2.0k 1.4× 1.9k 1.7× 1.2k 1.3× 156 6.7k
Ingo B. Runnebaum Germany 36 1.7k 0.9× 1.4k 0.9× 1.1k 0.8× 885 0.8× 384 0.4× 183 4.9k
Annette Staebler Germany 33 1.5k 0.8× 1.0k 0.7× 1.1k 0.7× 1.1k 1.0× 614 0.7× 125 4.8k
Colin J.R. Stewart Australia 39 1.9k 1.0× 1.7k 1.1× 2.7k 1.9× 1.8k 1.6× 1.3k 1.4× 208 6.7k
Catherine Lhommé France 33 949 0.5× 1.3k 0.8× 2.0k 1.4× 1.0k 0.9× 478 0.5× 119 4.2k
Naveena Singh United Kingdom 37 1.5k 0.8× 703 0.4× 2.1k 1.5× 1.8k 1.7× 650 0.7× 144 5.2k
Harry J. Long United States 36 1.7k 0.9× 915 0.6× 1.3k 0.9× 2.2k 1.9× 674 0.7× 95 4.8k

Countries citing papers authored by Patricia Pautier

Since Specialization
Citations

This map shows the geographic impact of Patricia Pautier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Pautier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Pautier more than expected).

Fields of papers citing papers by Patricia Pautier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Pautier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Pautier. The network helps show where Patricia Pautier may publish in the future.

Co-authorship network of co-authors of Patricia Pautier

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Pautier. A scholar is included among the top collaborators of Patricia Pautier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Pautier. Patricia Pautier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Blanc‐Durand, Félix, Damien Vasseur, Audrey Le Formal, et al.. (2024). An evaluation of cell-free tumor DNA from 20 mL of peritoneal fluid for homologous recombination deficiency (HRD) testing in newly diagnosed ovarian cancer (OC).. Journal of Clinical Oncology. 42(16_suppl). 5577–5577. 1 indexed citations
3.
Blanc‐Durand, Félix, Géraldine M. Camilleri, Arnaud Bayle, et al.. (2024). Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer. Cancer. 130(19). 3311–3320. 1 indexed citations
4.
5.
6.
Pautier, Patricia, Antoîne Italiano, Sophie Piperno‐Neumann, et al.. (2024). Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma. New England Journal of Medicine. 391(9). 789–799. 29 indexed citations
7.
Pautier, Patricia, Catherine Genestie, Laurence Gladieff, et al.. (2023). Recommandations pour la pratique clinique Nice/Saint-Paul-de-Vence 2022–2023 : Prise en charge du cancer du col de l'utérus avancé. Bulletin du Cancer. 110(6). 6S44–6S50.
8.
Blanc‐Durand, Félix, Sophie Cotteret, Catherine Genestie, et al.. (2023). Clinical Relevance of BRCA1 Promoter Methylation Testing in Patients with Ovarian Cancer. Clinical Cancer Research. 29(16). 3124–3129. 18 indexed citations
9.
Puszkiel, Alicja, Benoı̂t Blanchet, Nicolas Delanoy, et al.. (2021). Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study. Pharmaceuticals. 14(8). 804–804. 16 indexed citations
10.
Sessa, Cristiana, Dominik T. Schneider, François Planchamp, et al.. (2020). ESGO–SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers. The Lancet Oncology. 21(7). e360–e368. 63 indexed citations
11.
Tischkowitz, Marc, Sidong Huang, Susana Banerjee, et al.. (2020). Small-Cell Carcinoma of the Ovary, Hypercalcemic Type–Genetics, New Treatment Targets, and Current Management Guidelines. Clinical Cancer Research. 26(15). 3908–3917. 84 indexed citations
12.
Auguste, Aurélie, Félix Blanc‐Durand, Marc Deloger, et al.. (2020). Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis. Cells. 9(6). 1496–1496. 31 indexed citations
13.
Pautier, Patricia, Ignace Vergote, Florence Joly, et al.. (2016). A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer. International Journal of Gynecological Cancer. 27(2). 258–266. 32 indexed citations
14.
Oza, Amit M., Frédèric Selle, Ірина Давиденко, et al.. (2016). Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study. International Journal of Gynecological Cancer. 27(1). 50–58. 55 indexed citations
15.
Benbrahim, Zineb, et al.. (2015). Primitive Neuroectodermal Tumor of the Cervix Uteri: A case report and review of literature. SHILAP Revista de lepidopterología. 6(4). 30–32. 7 indexed citations
16.
Viaud, Sophie, Caroline Flament, Mustapha Zoubir, et al.. (2010). Cyclophosphamide Induces Differentiation of Th17 Cells in Cancer Patients. Cancer Research. 71(3). 661–665. 136 indexed citations
17.
Uzan, Catherine, Sébastien Gouy, Patricia Pautier, et al.. (2010). Lymphadénectomie lomboaortique dans les cancers du col de stade avancé : un standard en 2010 ?. Gynécologie Obstétrique & Fertilité. 38(11). 668–671. 4 indexed citations
18.
Haie-Méder, Christine, R. de Crevoisier, Catherine Lhommé, et al.. (2005). Associations chimioradiothérapie chez les patientes atteintes d’un carcinome du col utérin. Bulletin du Cancer. 92(12). 1032–1038. 3 indexed citations
19.
Pautier, Patricia, Philippe Morice, & R. de Crevoisier. (2003). Cancer du col et infection à VIH. Bulletin du Cancer. 90(5). 399–404. 1 indexed citations
20.
Morice, Philippe, Damienne Castaigne, Patricia Pautier, et al.. (1999). Interest of Pelvic and Paraaortic Lymphadenectomy in Patients with Stage IB and II Cervical Carcinoma. Gynecologic Oncology. 73(1). 106–110. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rochelle L. Garcia Breakdown of academic impact, for papers by Oluwole Fadare Breakdown of academic impact, for papers by Toru Sugiyama Breakdown of academic impact, for papers by Brooke E. Howitt Breakdown of academic impact, for papers by Ingo B. Runnebaum Breakdown of academic impact, for papers by Annette Staebler Breakdown of academic impact, for papers by Colin J.R. Stewart Breakdown of academic impact, for papers by Catherine Lhommé Breakdown of academic impact, for papers by Naveena Singh Breakdown of academic impact, for papers by Harry J. Long
Rankless by CCL
2026